Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Visual outcome following optic neuritis: A 5-year review.
Induced brain plasticity after a facilitation programme for autobiographical memory in multiple sclerosis: a preliminary study.
Multiple sclerosis and the blood-central nervous system barrier.
Initiation of Anti-TNF Therapy and the Risk of Optic Neuritis: From the Safety Assessment of Biologic ThERapy (SABER) Study.
CONTINUUM Multiple Sclerosis: Teaching Us About More Than MS and Its ABCs.
Alpha-B-crystallin induces an immune-regulatory and antiviral microglial response in preactive multiple sclerosis lesions.
Therapeutic targeting of STAT pathways in CNS autoimmune diseases.
Axonally derived matrilin-2 induces proinflammatory responses that exacerbate autoimmune neuroinflammation.
γδ T cells as early sensors of tissue damage and mediators of secondary neurodegeneration.
How to run a multiple sclerosis relapse clinic.
Effects of whole body vibration on hormonal & functional indices in patients with multiple sclerosis.
Relationship between subjective and objective cognitive performance in multiple sclerosis.
Natalizumab and fingolimod: Insight into their relative efficacies in clinical practice.
Neuroinflammation. Contemporary anti-inflammatory treatment approaches.
Dietary habits and selenium, glutathione peroxidase and total antioxidant status in the serum of patients with relapsing-remitting multiple sclerosis.
Age and disability drive cognitive impairment in multiple sclerosis across disease subtypes.
Nonlinear dynamical structure of sway path during standing in patients with multiple sclerosis and in healthy controls is affected by changes in sensory input and cognitive load.
Deficits in memory and visuospatial learning correlate with regional hippocampal atrophy in MS.
Pre- and postsynaptic type-1 cannabinoid receptors control the alterations of glutamate transmission in experimental autoimmune encephalomyelitis.
The innate immune adaptor MyD88 is dispensable for spontaneous autoimmune demyelination in a mouse model of multiple sclerosis.
Relevance of Spinal Cord Abnormalities to Clinical Disability in Multiple Sclerosis: MR Imaging Findings in a Large Cohort of Patients.
The relationship of age, function, and psychological distress in multiple sclerosis.
Helicobacter pylori infection as a protective factor against multiple sclerosis risk in females.
Promoting sympathovagal balance in multiple sclerosis; pharmacological, non-pharmacological, and surgical strategies.
Home functioning profiles in people with multiple sclerosis and their relation to disease characteristics and psychosocial functioning.
Pages
« first
‹ previous
…
373
374
375
376
377
378
379
380
381
…
next ›
last »